FEFatma Bilge Ergen

Fatma Bilge Ergen

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fatma Bilge Ergen has a total of 89 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Overuse Injuries in the Muscle–Tendon–Enthesis Unit

    by Fatma B. Ergen, İhSan Ş Örgüç

    Overuse injuries of the bone–tendon–muscle unit are a common yet underrecognized source of pain and dysfunction in athletes and the general population. They arise from repetitive mechanical loading and age-related degenerative changes that exceed the adaptive capacity of musculoskeletal tissues. Imaging is central to early detection, accurate characterization, and treatment planning. This review presents a practical, imaging-based framework using magnetic resonance imaging and radiography, emphasizing key diagnostic features, anatomical considerations, and classification. Content is organized into two complementary domains. The first addresses overuse injuries at the tendo-osseous junction, categorized by enthesis type—fibrous versus fibrocartilaginous—and by skeletal maturity, as well as injuries involving fibro-osseous tunnels, pulleys, and bony constraints. The second focuses on myotendinous and intramuscular injury, spanning early edema, fiber disruption, chronic remodeling, and changes related to aging and repetitive microtrauma. This integrated approach supports consistent evaluation across the bone–tendon–muscle continuum.

  • Atypical notochordal cell tumors: an alternative diagnosis when diagnostic criteria are not straightforward

    by H. Gokce Terzioglu, F. Bilge Ergen, A. Elçin Yıldız, A. Figen Soylemezoglu, Kemal Kosemehmetoglu

    Tumors with notochordal differentiation are categorized into two distinct entities in the latest WHO classification: benign notochordal cell tumor (BNCT) and chordoma. Previously, atypical notochordal cell tumor (ANCT) has been described for lesions that exhibit radiological and morphological features that deviate from BNCT and do not meet the criteria for chordoma. We present the clinicopathological and radiological findings of eight ANCT cases along with follow-up data. M: F was 2:6, with a mean age of 37 years. Tumors were located in the clivus (n = 3), coccyx (n = 3), thoracic vertebra (n = 1), and cervical vertebra (n = 1). The mean tumor size was 2 cm. Radiologically, features such as cortical erosion (n = 5), minimal soft-tissue extension (n = 3), and a predominant soft-tissue location (n = 2) were atypical. Morphologically, none of the tumors showed prominent cytological atypia or lobular growth. Only two cases exhibited focal minimal myxoid change, and one case showed focal necrosis. Previous diagnoses included chordoma (n = 3), ANCT (n = 3), and BNCT (n = 2). All patients are alive, with follow-up periods ranging from 2 months to 20 years (median 7.5 years), and there is no evidence of disease progression. We recommend using the term “atypical notochordal cell tumor” for tumors that do not fully meet the morphological and radiological criteria for BNCT or chordoma. This approach aims to ensure close patient follow-up and prevent unnecessary, extensive medical interventions.

  • Osteolipomas revisited: a detailed clinical, histologic and molecular characterisation

    by Rayan Rammal, Azfar Neyaz, Shaymaa Hegazy, Abigail I Wald, Fatma Bilge Ergen, Ivy John

    Aims: Lipomas are the most common mesenchymal neoplasms in adults, with osteolipomas representing a rare subtype characterised by metaplastic bone formation. The pathogenesis and molecular basis of osteolipomas remain poorly understood. While secondary ossification has been proposed as a potential mechanism, molecular characterisation of these tumours has been limited.Methods and results: We retrospectively analysed 18 cases of osteolipoma, evaluating clinical, radiologic and histopathologic features. Results of fluorescence in situ hybridisation (FISH) for MDM2 amplification were documented. Whole transcriptome sequencing (RNA‐seq) was performed on six tumours to identify potential gene fusions. Patients had a median age of 55 years (range, 34–73 years), with tumours primarily arising in the extremities. The majority were deep‐seated, and a subset had a history of prior trauma. Histologically, all cases exhibited mature adipocytes with variable amounts of metaplastic bone and cartilage. In several cases, stromal progression was observed, with fibrous septa transitioning into fibromyxoid nodules, cartilage and ultimately bone, supporting a metaplastic ossification process. RNA‐seq identified recurrent HMGA2 gene fusions, including HMGA2::LHFP, HMGA2::LPP and a novel HMGA2::PIK3R1 fusion, reinforcing their molecular similarity to conventional lipomas.Conclusions: Our findings support the classification of osteolipomas as conventional lipomas undergoing secondary osseous metaplasia. The identification of HMGA2 fusions, along with their predilection for trauma‐prone sites and the observed stromal progression towards bone, suggests a causal association with chronic mechanical stress. Recognising these features is critical to avoid misclassification, particularly as atypical lipomatous tumour/well‐differentiated liposarcoma.


  • Blood flow restriction training with cross education for quadriceps muscle recovery after anterior cruciate ligament reconstruction: A prospective, randomized, controlled, single‐blind clinical trial

    by Ceyda Sevinc, Volkan Gürler, Gulcan Harput, Ali Ocguder, F. Bilge Ergen, Volga Bayrakcı Tunay

    Purpose: Recently, blood flow restriction (BFR) and cross education (CE) trainings are the options for quadriceps strength recovery after anterior cruciate ligament reconstruction (ACLR). The aim of this study was to investigate the effects of CE combined with BFR on quadriceps strength and thickness after ACLR.Methods: Twenty‐four male patients [(Age: 24.9 ± 6.3 years, body mass index: 24 ± 2.3 kg/m2) who had undergone ACLR with hamstring autograft were included. At 4 weeks after surgery, the patients were randomly divided into two groups (Group‐1: CE + BFR, n = 13, Group‐2: CE, n = 11). All patients had standardized rehabilitation for their reconstructed limb until 12 weeks postsurgery, and they all received CE training for uninjured limb at isokinetic system (quadriceps eccentric contraction, 60°/s 3‐set 12‐rep, 2‐days in a week) during 8 weeks. Group 2 performed the same CE procedure with BFR. Quadriceps isometric strength was measured using an isokinetic dynamometer, while the thickness of quadriceps (rectus femoris, vastus lateralis, vastus medialis obliquus) and cross‐sectional area of rectus femoris were evaluated using ultrasound pretraining (4th‐week postsurgery) and posttraining (12th‐week postsurgery). Analysis of variance was used for statistical analysis.Results: Group‐by‐time interaction and the group main effect were not significant for any measured variables in both limbs (p > 0.05). There was a significant main effect of time observed for quadriceps strength and thickness in involved and uninvolved limbs (p < 0.001, p < 0.05, respectively). In Group 1, the limb symmetry index for quadriceps strength increased from 49.3% to 71.7%, while in Group 2, it increased from 50.9% to 75.2%.Conclusion: BFR training, adapted to CE eccentric strengthening, may not be effective for quadriceps muscle strength recovery after ACLR. Further investigations with varied training protocols are needed to research the impact of BFR on CE.Level of Evidence: Level II randomized controlled trial.


  • Soft tissue mass resembling myxochondroid metaplasia in Achilles tendon

    by F. Bilge Ergen, Rana Naous, Sophie Darwiche, Jonathan Daniel Hughes, Lucas Da Gama Labo, Cynthia Britton

    The Achilles tendon is the strongest and largest tendon in the human body, composed of the distal confluence of the gastrocnemius and soleus muscles and may also include the plantaris longus tendons. Despite its tremendous strength, it is frequently injured. Soft tissue tumors or tumor-like conditions of Achilles tendon are much less common in comparison to traumatic and infectious/inflammatory lesions. These include giant cell tumor of the tendon sheath, pigmented villonodular synovitis, xanthomas, hematomas, and tophaceous gout. We present a case of a myxochondroid mass arising from the Achilles tendon in a 17-year-old female softball player detected after a minor trauma. According to our knowledge, this is the first case reported in the literature detailing the radiological findings and histopathological diagnosis of a myxochondroid mass arising from a tendon.

  • Open Access

    Sacroiliac joint involvement in osteochondromatosis: its prevalence and characteristics on cross-sectional imaging

    by Sevtap Arsla, Adalet Elcin Yildiz, Fatma Bilge Ergen, Ustun Aydingoz

    PURPOSEApart from a few case reports, sacroiliac joint (SIJ) involvement in osteochondromatosis has not been studied. We aimed to determine the prevalence and characteristics of such involvement using cross-sectional imaging. METHODSIn this retrospective study, three observers (one junior radiologist and two musculoskeletal radiol-ogists) independently reviewed computed tomography (CT) or magnetic resonance imaging (MRI) of patients in our database who had osteochondromatosis (& GE;2 osteochondromas across the skele-ton) for SIJ involvement. The final decision was reached by the consensus of the two musculoskele-tal radiologists in a later joint session. RESULTSOf the 36 patients with osteochondromatosis in our database, 22 (61%) had cross-sectional im-aging covering SIJs (14 females, 8 males; age range 7-66 years; mean age 23 years; 13 MRI, 9 CT). Of these, 16 (73%) had intra-articular osteochondromas. For identifying SIJ osteochondromas on cross-sectional imaging, interobserver agreement was substantial [& kappa; = 0.67; 95% confidence inter-val (CI): 0.34, 1.00] between the musculoskeletal radiologists and moderate (& kappa; = 0.59; 95% CI: 0.23, 0.94) between the junior radiologist and the final consensus decision of the two musculoskeletal radiologists. In the cohort with cross-sectional imaging, the anatomical variations of the accessory SIJ (n = 6, 27%) and iliosacral complex (n = 2, 9%) were identified in six different patients with (n = 2) and without (n = 4) sacroiliac osteochondromas. CONCLUSIONCross-sectional imaging shows frequent (73%) SIJ involvement in osteochondromatosis, which, al-though a rare disorder, nevertheless needs to be considered in the differential diagnosis of such SIJ anatomical variants as the accessory SIJ and iliosacral complex. Differentiating these variants from osteochondromas is challenging in patients with osteochondromatosis.

  • Top Cited Papers

    Zero Echo Time Musculoskeletal MRI: Technique, Optimization, Applications, and Pitfalls

    by Üstün Aydıngöz, Adalet Elçin Yıldız, F. Bilge Ergen

    Zero echo time musculoskeletal MRI is a novel technique that generates images similar to those of CT or radiography, thereby opening new possibilities for one-stop imaging of a wide spectrum of con... Zero echo time (ZTE) imaging is an MRI technique that produces images similar to those obtained with radiography or CT. In ZTE MRI, the very short T2 signal from the mineralized trabecular bone mat...


  • Investigation of the relationship between soft tissue flexibility and acromiohumeral distance in subacromial pain syndrome

    by Leyla Eraslan, Ozan Yar, Bilge Ergen, Gazi Huri̇, İrem Düzgün

    Amaç: Bu çalışmanın amacı, subakromiyal ağrı sendromlu hastalardaki omuz çevresi yumuşak doku esneklik kaybının araştırılması ve akromiyohumeral mesafe (AHM) arasındaki ilişkinin ortaya koyulması idi.Yöntem: Bu araştırmaya subakromiyal ağrı sendromu tanısı konulan 22 hasta (12 kadın, 10 erkek, ortalama yaş: 31,2±8,6 yıl, ortalama VKİ: 22,8±2,8 kg/m2) dahil edildi. Hastaların eklem hareket açıklıkları standart gonyometre, skapular diskinezi “var/yok yöntemi”, posterior kapsül esnekliği “Horizontal Adduksiyon Testi” ve pectoralis minor esnekliği “Pectoralis Minor Uzunluk Testi” kullanılarak ölçüldü. AHM ölçümleri hastaların istirahat postürlerinde ultrasonografi kullanılarak yapıldı. İstatistiksel analizde, etkilenen ve sağlam omuz arasındaki yumuşak doku esneklik farkı “bağımlı gruplarda t-testi”, yumuşak doku esneklikleri ile AHM arasındaki ilişki Pearson Korelasyon Katsayısı kullanılarak analiz edildi.Bulgular: Hastaların sağlam omuzları ile kıyaslandığında etkilenen omuzlarında posterior kapsül esnekliği (p=0,008) ve pectoralis minor esnekliği (p0,05).Sonuç: Genel olarak bakıldığında subakromiyal ağrı sendromlu hastaların etkilenen omuzlarının yumuşak doku esnekliklerinin sağlam tarafa göre azaldığı bulundu. Ancak hem etkilenen hem sağlam taraf pectoralis minor ve posterior kapsül esnekliklerinin istirahat AHM ölçümleri ile ilişkili olmadığı sonucuna varıldı. Bu sonuçlara göre omuz çevresi yumuşak doku esneklik kaybı istirahat AHM değişimleri üzerinde önemli bir rolü olmadığı, subakromiyal sıkışmaya neden olabilecek diğer faktörlerin göz önünde bulundurulması gerektiği düşüncesindeyiz.


  • Different Attenuation Models of Diffusion‐Weighted MR Imaging for the Differentiation of Benign and Malignant Musculoskeletal Tumors

    by Sevtap Arslan, Fatma Bilge Ergen, Güzide Burça Aydın, Mehmet Ayvaz, Jale Karakaya, Kemal Kösemehmetoğlu, Adalet Elçin Yıldız, Üstün Aydıngöz

    Background: Several functional imaging techniques, including monoexponential diffusion‐weighted imaging (m‐DWI), intravoxel incoherent motion (IVIM), and diffusion kurtosis (DK) imaging, have been used in differentiating benign and malignant musculoskeletal tumors. Combining all three techniques in the same study population may improve differentiation.Purpose: To compare the diagnostic performance of m‐DWI, IVIM, and DK models and their combinations in differentiating benign and malignant musculoskeletal tumors.Study Type: Prospective.Population: Fifty patients with benign and malignant musculoskeletal tumors divided into nonmyxoid and nonchondroid and myxoid and/or chondroid subgroups.Field strength/Sequence: A 1.5 T/m‐DWI, IVIM, and DK single‐shot spin‐echo echo‐planar sequences.Assessment: Minimum and volumetric values of apparent diffusion coefficient (ADC), pure molecular diffusion (Divim), pseudodiffusion (D*), perfusion fraction (f), diffusion coefficient for kurtosis model (DK), and Kurtosis (K) were compared between all benign and malignant tumors. Subgroup analysis was also performed for nonmyxoid and nonchondroid and myxoid and/or chondroid tumors.Statistical tests: Independent samples t‐test, Mann–Whitney U test, intraclass correlation coefficient, ROC analysis, and logistic regression analysis. A P value < 0.05 was considered statistically significant.Results: ADCmin, Divim‐min, D*vol, DK‐min, Kvol, and Kmin values showed statistically significant differences between all benign and malignant tumors and nonmyxoid and nonchondroid tumor subgroup. Kmin showed the highest diagnostic performance in differentiating benign and malignant tumors with AUCs of 0.760 for “all tumors” and 0.825 for the nonmyxoid and nonchondroid tumor subgroup. No significant differences were detected in m‐DWI‐, IVIM‐, and DK‐derived parameters for differentiating benign and malignant myxoid and/or chondroid tumors. Only three of 63 combinations of prediction models demonstrated a higher diagnostic performance than Kmin; however, improvements were not significantly different.Data conclusion: ADCmin, Divim‐min, D*vol, DK‐min, Kvol, and Kmin values can be used to differentiate benign and malignant musculoskeletal tumors. Our findings suggest that the added value of multiparametric approach in such differentiation is not significant.Evidence Level: 1Technical Efficacy: Stage 2


  • Open Access

    Reactivation of inflammatory monoarthritis during dupilumab treatment used for prurigo nodularis

    by Ecem Bostan, Duygu Gülseren, Zehra Özsoy, Fatma Bilge Ergen

    Dupilumab is a humanized monoclonal antibody which specifically targets interleukin-4/interleukin-13 receptor and is primarily indicated for the treatment of atopic dermatitis, although it has been shown to be efficacious in various disorders including asthma, chronic rhinosinusitis, prurigo nodularis.[1] Herein, we report an extraordinary case related to the exacerbation of inflammatory arthritis in a patient under dupilumab treatment for prurigo nodularis. An 18-year-old woman with a history of allergic rhinitis and atopic dermatitis, presented for her pruritic lesions. The pruritic nodules started from the lumbar area nine years ago and subsequently spread to entire body. Topical corticosteroids, oral antihistamines, systemic corticosteroids, and methotrexate were prescribed with no long-term benefits. Dermatological examination revealed hyperkeratotic plaques involving the trunk and extremities. Histopathological evaluation of the lesions was compatible with the diagnosis of prurigo nodularis. She was started on oral cyclosporine 200 mg for seven months; however, within the last month of cyclosporine treatment, her complaints increased, leading us to switch to dupilumab. Although her clinical manifestations and pruritus improved, she developed mild right knee swelling, warmness, and arthralgia after the first maintenance dose following the loading dose. Upon questioning, we recognized that the patient developed reactive arthritis in the right knee, when she was 10 years old. Until now, she stayed asymptomatic. She was consulted to rheumatology department and effusion was detected by right knee ultrasonography and arthrocentesis was performed which revealed no bacterial growth. Elevated C-reactive protein and erythrocyte sedimentation levels were noted. Rheumatological markers were all negative. Right knee magnetic resonance imaging showed moderate effusion along with synovial proliferation consistent with synovitis; no periarticular erosion, osteitis or ligamentous anomaly were detected (Figure 1). She was diagnosed with dupilumab-induced exacerbation of inflammatory arthritis and was started on oral diclofenac and intraarticular steroid injection which resulted in symptomatic relief. Therefore, dupilumab treatment was continued. Dupilumab is the first biological agent approved for the treatment of refractory atopic dermatitis. Similar to the other biological agents, dupilumab is reported to have various side effects.[2] Most commonly reported side effect was conjunctivitis, followed by headache, muscle/joint pain, and injection site reactions.[2] Inflammatory arthritis is an underrecognized complication of dupilumab. De Wijs et al.[3] reported a case of acute inflammatory polyarthritis observed in an atopic dermatitis patient after one month of dupilumab therapy. Willsmore et al.[4] described a possible relationship between new-onset seronegative arthropathy, enthesitis, and dupilumab. The pathogenesis of dupilumab-induced arthritis is unknown; however, the blockage of interleukin-4 and interleukin-13 may increase the levels of inflammatory cytokines such as tumor necrosis factor alpha and interleukin-6.[5] Furthermore, inhibition of T helper (Th)2 pathway, may potentially cause compensatory activation in Th17 pathway which is related to peripheral spondyloarthritis and inflammatory arthritis.[4] In conclusion, we emphasize the fact that exacerbation in inflammatory arthritis can be encountered during dupilumab treatment. Dermatologists should be aware of this rare side effect of dupilumab and an urgent rheumatological consultation must be sought for proper diagnosis and treatment.